INVA Q2 2020 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$79M+23.1% YoY

Gross Profit

$79M100.0% margin

Operating Income

$76M96.0% margin

Net Income

$77M97.3% margin

EPS (Diluted)

$0.69

QoQ Revenue Growth

+0.3%

Cash Flow

Operating Cash Flow

$80M

Free Cash Flow

$80M

Stock-Based Comp.

$375,000

Balance Sheet

Total Assets

$880M

Total Liabilities

$387M

Stockholders' Equity

$457M

Cash & Equivalents

$413M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$64M	+23.1%
Gross Profit	$79M	$64M	+23.1%
Operating Income	$76M	$60M	+26.8%
Net Income	$77M	$38M	+103.6%